OsteoMed, a privately held medical device company in Addison, Texas, is launching OsteoVation QWIK, its product designed to fill bony voids and gaps of the skeletal system. A composite of calcium phosphate and calcium sulfate granules, the material, according to a company release, creates a macroporous construct that allows for faster bone remodeling while maintaining targeted compressive strength.
New Bone-Filler Speeds Bone Remodeling
1 min read Premium comments
Secondary
The company has packaged OsteoVation QWIK in impact and inject formulas to provide surgical options for both open and minimally-invasive surgical procedures. Officials report that both formulations are osteoconductive and provide a scaffold to enhance the bone during the healing process. Company officials report that OsteoVation QWIK is one of several new products the firm is scheduled to launch in 2013.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.